These results align with a previous study conducted in patients with gastrointestinal disorders treated with omeprazole, where therapeutic failure was associated with the CYP2C:TG/TG diplotype, but not with the increased-function variant CYP2C19*17 [19]. This evidence concerns the gene CYP2C19 and digestive system disorder.